ArticleThe Korean journal of internal medicine2021

Metformin enhances the cytotoxic effect of nilotinib and overcomes nilotinib resistance in chronic myeloid leukemia cells.

Yoo Jin Na et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.